Brief: Can-Fite Reports Third Quarter 2021 Financial Results & Provides Clinical Update
26/11/2021 12:57
Nov 26 (Reuters) - Can Fite Biopharma Ltd CANF.TA :
* CAN-FITE REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS &
PROVIDES
CLINICAL UPDATE
* CAN FITE BIOPHARMA LTD - EXPECT RESEARCH AND DEVELOPMENT
EXPENSES WILL INCREASE FOR REMAINDER OF 2021 AND BEYOND
Source text for Eikon: ID:nBw6RpRW6a
Further company coverage: CANF.TA
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Can Fite Biopharma
See all newsBrief: Corrected-Can Fite Biopharma Ltd Files For Offering Of Up To 6.6 mln Ordinary Shares By Selling Shareholders
Can-Fite BioPharma rises after longer-than-anticipated overall survival in ongoing liver cancer study
Can-Fite BioPharma reports longer-than-anticipated overall survival in ongoing liver cancer study
Brief: Can Fite Biopharma Can-Fite Submits Phase 2 Study Protocol For Piclidenoson In Lowe Syndrome
Can-Fite rises as skin drug study reaches interim analysis stage